DUBLIN--(BUSINESS WIRE)--The "Global Pain Management Drugs Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The pain management drugs market will register a CAGR of nearly 4% by 2022.
Numerous diseases and conditions are associated with pain, including arthritis, peripheral neurology, fibromyalgia and shingles
Low back pain is a common health problem in the workplace and most people are expected to experience symptoms of low back pain during their working life. Such an increase in the prevalence of chronic pain conditions will drive the global pain management drugs market during our forecast period.
Strong pipeline and recently approved pain management drugs
Most of the therapeutics that are in the last stage of development are expected to get marketing approval during our forecast period. Apart from the strong pipeline of late-stage molecules, recent approvals are expected to drive the global pain management drugs market.
High influx of generic drugs
Patent cliff and high prices of branded drugs result in a high influx of genetic drugs. The major reasons behind high drug prices are drug regulatory policies or industrial pricing strategies, and policy measures.
Key Players
- Endo Pharmaceuticals
- GlaxoSmithKline
- Johnson & Johnson
- Pfizer
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: PIPELINE ANALYSIS
PART 06: MARKET SIZING
PART 07: FIVE FORCES ANALYSIS
PART 08: MARKET SEGMENTATION BY PAIN TYPES
- Segmentation by pain types
- Nociceptive pain
- Neuropathic pain
- Psychogenic pain
PART 09: MARKET SEGMENTATION BY PRODUCT
- Segmentation by product
- Comparison by product
- Opioids - Market size and forecast 2017-2022
- NSAIDs - Market size and forecast 2017-2022
- Others - Market size and forecast 2017-2022
- Market opportunity by product
PART 10: CUSTOMER LANDSCAPE
PART 11: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas - Market size and forecast 2017-2022
- EMEA - Market size and forecast 2017-2022
- APAC - Market size and forecast 2017-2022
- Market opportunity
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
PART 14: MARKET TRENDS
- Increase in prevalence of pain associated with chronic diseases
- Significant increase in the use of opioids for pain management
- Novel drug delivery systems and novel targets for pain management
PART 15: VENDOR LANDSCAPE
PART 16: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Endo Pharmaceuticals
- GlaxoSmithKline
- Johnson & Johnson
- Pfizer
For more information about this report visit https://www.researchandmarkets.com/research/p9tfhr/global_pain?w=4